ENHANCING ORAL BIOAVAILABILITY OF CARVEDILOL USING SOLID DISPERSION TECHNIQUE

Authors

  • Margrit Ayoub Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
  • Azza Hasan
  • Hanan El Nahas
  • Fakhr-eldin Ghazy

Keywords:

Carvedilol, solid dispersion, physical mixture, hypertension and oral bioavailability

Abstract

Objective: Carvedilol (CRV) is a beta blocker drug that is basically used for the treatment of hypertension, heart failure and arrhythmias. The objective of this study is to increase the oral bioavailability of CRV by using solid dispersions to enhance its solubility and dissolution rate.

Methods: Various preparations of CRV-solid dispersions (SDs) and physical mixtures (PMs) were prepared using different carriers; polyethylene glycol (PEG) 4000, polyvinyl pyrrolidone (PVP) K30 and tartaric acid. Effect of type and concentrations of carriers on solubility and dissolution of CRV were studied. Selected CRV-SDs and PMs that showed the best solubility and dissolution were exposed for further investigations e. g. Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC) and X-ray diffraction (XRD). In addition, the oral antihypertensive activity of the optimized formula compared to pure CRV was evaluated in induced hypertensive adult albino male rats.

Results: All carriers enhanced the dissolution rate of CRV. Tartaric acid had the most persuasive effect on the rate and the extent of dissolution of CRV, followed by PEG4000 and PVP. FTIR, DSC and XRD diffraction revealed an interaction between CRV and tartaric acid with the possibility of a polymorphic change in CRV. The optimized formula CRV-tartaric acid (SD 1:0.3) causes a marked increase in the antihypertensive activity compared to pure CRV.

Conclusion: Tartaric acid is a promising and efficient carrier for improving the solubility, dissolution and oral bioavailability of CRV.

Keywords: Carvedilol, Solid dispersion, Physical mixture, Hypertension, Oral bioavailability

Downloads

Download data is not yet available.

References

Saharan AV, Kukkar V, Kataria M, Gera M, Choudhury PK. Dissolution enhancement of drugs. Int J Health Res 2009;2:107-24.

Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281-302.

Huang Y, Dai WG. Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharm Sin B 2014;4:18-25.

Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. American Pharmaceutical Association, Washington, and Pharmaceutical Press: London; 2009. p. 136-38, 517-22, 525-33.

Sharma A, Jain CP. A promising technique to enhance the solubility of poorly water soluble drug. Int J Drug Delivery 2011;3:149-70.

Brook CS, Chen W, Spoors PG. Carvedilol phosphate salts and/or solvates thereof, corresponding compositions and/or methods of treatment. US Patent 2007;7:268,156.

Yuvaraja K, Jasmina Khanam. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers, and hydroxyl acid. J Pharm Biomed Anal 2014;96:10–20

Shinkar DM, Dhake AS, Setty CM. Solubility and dissolution enhancement of carvedilol by solid dispersion technique using gelucire 50/13. Int J Pharm Sci Rev Res 2014;31:161-5.

Sharma A, Jain CP. Preparation and characterization of solid dispersions of carvedilol with PVP K30. Int J Pharm Sci Rev Res 2010;5:49–56.

Sharma A, Jain CP, Tanwar YS. Preparation and characterization of solid dispersions of carvedilol with poloxamer188. J Chil Chem Soc 2013;58:1553-7.

Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instrum 1965;4:117-212.

Gupta S, Ranawat MS. Effect of hydrophilic polymers on solubility enhancement of oral antidiabetic agent by solid dispersion technique. Asian J Biochem Pharm Res 2012;2:299-306.

Bobe KR, Subrahmanya CR, Suresh S, Gaikwad DT, Patil MD, Khade TS, et al. Formulation and evaluation of the solid dispersion of atorvastatin with various carriers. Int J Comprehensive Pharm 2011;1:1-6.

Nokhodchi A, Talari R, Valizadeh H, Jalali MB. An investigation on the solid dispersions of chlordiazepoxide. Int J Biomed Sci 2007;3:210-6.

Wurster DE, Taylor PW. Dissolution kinetics of certain crystalline forms of prednisolone. J Pharm Sci 1965;142:189-98.

Makky AMA, Ahmed ISA, EL-Nabarawi MA, Abd El-Moneim RA. Development of a new carvedilol tablet with rapid onset of action. Am J Drug Discovery Dev 2012;2:55-71.

Parasuraman S, Raveendran R. Measurement of invasive blood pressure in rats. J Pharmacol Pharmacother 2012;3:172–7.

Zheng L, Sun Z, Li J, Zhang R. Pulse pressure and mean arterial pressure in relation to ischemic stroke among patients with uncontrolled hypertension in rural areas of China. Stroke 2008;39:1932-7.

Shamma RN, Basha M. A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: formulation design and effect of the method of preparation. Powder Technol 2013;237:406-14.

Dhillon N, Midha K, Nagpal M, Pahwa R. Formulation, optimization and characterization of a solid dispersion of glibenclamide. Pharm Methods 2015;6:72-81.

Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm 2012;1-10. Doi:10.5402/2012/195727. [Article in Press]

Arias MJ, Gines JM, Moyano JR, Rabasco AM. Dissolution properties and in vivo behaviour of triametrene in solid dispersions with polyethylene glycols. Pharm Acta Helv 1996;71:229-35.

Torrado S, Torrado J, Cadorniga R. Preparation, dissolution and characterization of albendazole solid dispersions. Int J Pharm 1996;140:247-50.

Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. Int J Pharm 1996;143:59-66.

Van den Mooter G, Augustijns P, Blaton N, Kinget R. Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm 1998;164:67-80.

Chawla G, Bansal AK. Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives. Acta Pharm 2008;58:257–74.

Jahangiri A, Barzegar-Jalali M, Garjani A. Physicochemical characterization and pharmacological evaluation of ezetimibe-PVP K30 solid dispersions hyperlipidemic rats. Colloids Surf B 2015;134:423-30.

Tiwari R, Tiwari G, Srivastava B. Solid dispersions: an overview to modify bioavailability of poorly water soluble drugs. Int J PharmTech Res 2013;1:1338-49.

Akiladevi D, Shanmugapandiyan P, Jebasingh D, Basak S. Preparation and evaluation of paracetamol by solid dispersion technique. Int J Pharm Pharm Sci 2011;3:188-91.

Samy AM, Marzouk MA, Ammar AA, Ahmed MK. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique. Drug Discoveries Ther 2010;4:77-84.

Kumar O, Rani AP, Kumar DV. Formulation and evaluation of solid dispersions of flurbiprofen for dissolution rate enhancement. J Chem Pharm Res 2011;3:277-87.

Mudgal SS, Pancholi SS. Formulation of solid glibenclamide dispersions by solvent evaporation technique. J Chem Pharm Res 2012;4:353-9.

Choi DS, Sandhu H, Shah N. Amorphous solid dispersions: Theory and Practice. Library of congress control London; 2014. p. 125

Sherif EE, Fakhr-eldin SG, Ahmed SZ, Tamer MS. Solid dispersion approach for optimized bioavailability of sulpiride. Latin Am J Pharm 2013;32:902-10.

Kalaiselvan R, Mohanta GP, Madhusudan S, Manna PK, Manavalan R. Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques. Pharmazie 2007; 62:604-7.

Published

01-07-2016

How to Cite

Ayoub, M., A. Hasan, H. El Nahas, and F.- eldin Ghazy. “ENHANCING ORAL BIOAVAILABILITY OF CARVEDILOL USING SOLID DISPERSION TECHNIQUE”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 7, July 2016, pp. 193-9, https://journals.innovareacademics.in/index.php/ijpps/article/view/11614.

Issue

Section

Original Article(s)